Lumexa Imaging Holdings (LMRI, Health Care Services) Stock Valuation & Fair Value No P/E valuation
Lumexa Imaging Holdings (LMRI, Health Care Services) trades at a blended P/E of 31.8, trading without a historical P/E to compare against, with a forward growth estimate of 59.7% and a PEG of 0.53.
This company has no P/E to compare against its own history, so tickerseer publishes no valuation rating for it. The figures below are unaffected.
Valuation flags
- No P/E valuation to compare against
Verdict history
tickerseer has published no valuation rating since 2026-08-07, because this company has no P/E to compare against its own history.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, and the cheapest and dearest.
Frequently asked questions
Is Lumexa Imaging Holdings stock overvalued?
At a blended P/E of 31.8, Lumexa Imaging Holdings has no historical normal P/E on record to compare that against, with a PEG of 0.53 on 59.7% forward growth. tickerseer therefore publishes no valuation rating for it.
What is Lumexa Imaging Holdings's fair value and PEG?
Lumexa Imaging Holdings trades at a blended P/E of 31.8, a PEG of 0.53, and a forward growth estimate of 59.7%.
Has tickerseer's rating of Lumexa Imaging Holdings changed?
tickerseer has published no valuation rating since 2026-08-07, because this company has no P/E to compare against its own history.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.